A Liposomal Formulation Able to Incorporate a High Content of Paclitaxel and Exert Promising Anticancer Effect

Figure 1

The DSC thermographs for the EPC/HEPC (4 : 1) liposomes without the drug as well as with 7 and 14 mol% paclitaxel.